Regulation of soluble guanylyl cyclase redox state by hydrogen sulfide

Zongmin Zhou, Emil Martin, Iraida Sharina, Iolanda Esposito, Csaba Szabo, Mariarosaria Bucci, Giuseppe Cirino, Andreas Papapetropoulos

    Research output: Contribution to journalArticle

    29 Citations (Scopus)

    Abstract

    Soluble guanylate cyclase (sGC) is a receptor for nitric oxide (NO). Binding of NO to ferrous (Fe2+) heme increases its catalytic activity, leading to the production of cGMP from GTP. Hydrogen sulfide (H2S) is a signaling molecule that exerts both direct and indirect anti-oxidant effects. In the present, study we aimed to determine whether H2S could regulate sGC redox state and affect its responsiveness to NO-releasing agents and sGC activators. Using cultured rat aortic smooth muscle cells, we observed that treatment with H2S augmented the response to the NO donor DEA/NO, while attenuating the response to the heme-independent activator BAY58-2667 that targets oxidized sGC. Similarly, overexpression of H2S-synthesizing enzyme cystathionine-γ lyase reduced the ability of BAY58-2667 to promote cGMP accumulation. In experiments with phenylephrine-constricted mouse aortic rings, treatment with rotenone (a compound that increases ROS production), caused a rightward shift of the DEA/NO concentration-response curve, an effect partially restored by H2S. When rings were pre-treated with H2S, the concentration-response curve to BAY 58-2667 shifted to the right. Using purified recombinant human sGC, we observed that treatment with H2S converted ferric to ferrous sGC enhancing NO-donor-stimulated sGC activity and reducing BAY 58-2667-triggered cGMP formation. The present study identified an additional mechanism of cross-talk between the NO and H2S pathways at the level of redox regulation of sGC. Our results provide evidence that H2S reduces sGC heme Fe, thus, facilitating NO-mediated cellular signaling events.

    Original languageEnglish (US)
    Pages (from-to)556-562
    Number of pages7
    JournalPharmacological Research
    Volume111
    DOIs
    StatePublished - Sep 1 2016

    Fingerprint

    Hydrogen Sulfide
    Oxidation-Reduction
    Nitric Oxide
    Heme
    Nitric Oxide Donors
    Cystathionine
    Soluble Guanylyl Cyclase
    Rotenone
    Lyases
    Phenylephrine
    Guanosine Triphosphate
    Smooth Muscle Myocytes
    Antioxidants

    Keywords

    • cGMP
    • HS
    • Nitric oxide
    • ROS
    • sGC activators

    ASJC Scopus subject areas

    • Pharmacology

    Cite this

    Regulation of soluble guanylyl cyclase redox state by hydrogen sulfide. / Zhou, Zongmin; Martin, Emil; Sharina, Iraida; Esposito, Iolanda; Szabo, Csaba; Bucci, Mariarosaria; Cirino, Giuseppe; Papapetropoulos, Andreas.

    In: Pharmacological Research, Vol. 111, 01.09.2016, p. 556-562.

    Research output: Contribution to journalArticle

    Zhou, Zongmin ; Martin, Emil ; Sharina, Iraida ; Esposito, Iolanda ; Szabo, Csaba ; Bucci, Mariarosaria ; Cirino, Giuseppe ; Papapetropoulos, Andreas. / Regulation of soluble guanylyl cyclase redox state by hydrogen sulfide. In: Pharmacological Research. 2016 ; Vol. 111. pp. 556-562.
    @article{10ade44228a84ba280ed19a9456c13b7,
    title = "Regulation of soluble guanylyl cyclase redox state by hydrogen sulfide",
    abstract = "Soluble guanylate cyclase (sGC) is a receptor for nitric oxide (NO). Binding of NO to ferrous (Fe2+) heme increases its catalytic activity, leading to the production of cGMP from GTP. Hydrogen sulfide (H2S) is a signaling molecule that exerts both direct and indirect anti-oxidant effects. In the present, study we aimed to determine whether H2S could regulate sGC redox state and affect its responsiveness to NO-releasing agents and sGC activators. Using cultured rat aortic smooth muscle cells, we observed that treatment with H2S augmented the response to the NO donor DEA/NO, while attenuating the response to the heme-independent activator BAY58-2667 that targets oxidized sGC. Similarly, overexpression of H2S-synthesizing enzyme cystathionine-γ lyase reduced the ability of BAY58-2667 to promote cGMP accumulation. In experiments with phenylephrine-constricted mouse aortic rings, treatment with rotenone (a compound that increases ROS production), caused a rightward shift of the DEA/NO concentration-response curve, an effect partially restored by H2S. When rings were pre-treated with H2S, the concentration-response curve to BAY 58-2667 shifted to the right. Using purified recombinant human sGC, we observed that treatment with H2S converted ferric to ferrous sGC enhancing NO-donor-stimulated sGC activity and reducing BAY 58-2667-triggered cGMP formation. The present study identified an additional mechanism of cross-talk between the NO and H2S pathways at the level of redox regulation of sGC. Our results provide evidence that H2S reduces sGC heme Fe, thus, facilitating NO-mediated cellular signaling events.",
    keywords = "cGMP, HS, Nitric oxide, ROS, sGC activators",
    author = "Zongmin Zhou and Emil Martin and Iraida Sharina and Iolanda Esposito and Csaba Szabo and Mariarosaria Bucci and Giuseppe Cirino and Andreas Papapetropoulos",
    year = "2016",
    month = "9",
    day = "1",
    doi = "10.1016/j.phrs.2016.06.029",
    language = "English (US)",
    volume = "111",
    pages = "556--562",
    journal = "Pharmacological Research",
    issn = "1043-6618",
    publisher = "Academic Press Inc.",

    }

    TY - JOUR

    T1 - Regulation of soluble guanylyl cyclase redox state by hydrogen sulfide

    AU - Zhou, Zongmin

    AU - Martin, Emil

    AU - Sharina, Iraida

    AU - Esposito, Iolanda

    AU - Szabo, Csaba

    AU - Bucci, Mariarosaria

    AU - Cirino, Giuseppe

    AU - Papapetropoulos, Andreas

    PY - 2016/9/1

    Y1 - 2016/9/1

    N2 - Soluble guanylate cyclase (sGC) is a receptor for nitric oxide (NO). Binding of NO to ferrous (Fe2+) heme increases its catalytic activity, leading to the production of cGMP from GTP. Hydrogen sulfide (H2S) is a signaling molecule that exerts both direct and indirect anti-oxidant effects. In the present, study we aimed to determine whether H2S could regulate sGC redox state and affect its responsiveness to NO-releasing agents and sGC activators. Using cultured rat aortic smooth muscle cells, we observed that treatment with H2S augmented the response to the NO donor DEA/NO, while attenuating the response to the heme-independent activator BAY58-2667 that targets oxidized sGC. Similarly, overexpression of H2S-synthesizing enzyme cystathionine-γ lyase reduced the ability of BAY58-2667 to promote cGMP accumulation. In experiments with phenylephrine-constricted mouse aortic rings, treatment with rotenone (a compound that increases ROS production), caused a rightward shift of the DEA/NO concentration-response curve, an effect partially restored by H2S. When rings were pre-treated with H2S, the concentration-response curve to BAY 58-2667 shifted to the right. Using purified recombinant human sGC, we observed that treatment with H2S converted ferric to ferrous sGC enhancing NO-donor-stimulated sGC activity and reducing BAY 58-2667-triggered cGMP formation. The present study identified an additional mechanism of cross-talk between the NO and H2S pathways at the level of redox regulation of sGC. Our results provide evidence that H2S reduces sGC heme Fe, thus, facilitating NO-mediated cellular signaling events.

    AB - Soluble guanylate cyclase (sGC) is a receptor for nitric oxide (NO). Binding of NO to ferrous (Fe2+) heme increases its catalytic activity, leading to the production of cGMP from GTP. Hydrogen sulfide (H2S) is a signaling molecule that exerts both direct and indirect anti-oxidant effects. In the present, study we aimed to determine whether H2S could regulate sGC redox state and affect its responsiveness to NO-releasing agents and sGC activators. Using cultured rat aortic smooth muscle cells, we observed that treatment with H2S augmented the response to the NO donor DEA/NO, while attenuating the response to the heme-independent activator BAY58-2667 that targets oxidized sGC. Similarly, overexpression of H2S-synthesizing enzyme cystathionine-γ lyase reduced the ability of BAY58-2667 to promote cGMP accumulation. In experiments with phenylephrine-constricted mouse aortic rings, treatment with rotenone (a compound that increases ROS production), caused a rightward shift of the DEA/NO concentration-response curve, an effect partially restored by H2S. When rings were pre-treated with H2S, the concentration-response curve to BAY 58-2667 shifted to the right. Using purified recombinant human sGC, we observed that treatment with H2S converted ferric to ferrous sGC enhancing NO-donor-stimulated sGC activity and reducing BAY 58-2667-triggered cGMP formation. The present study identified an additional mechanism of cross-talk between the NO and H2S pathways at the level of redox regulation of sGC. Our results provide evidence that H2S reduces sGC heme Fe, thus, facilitating NO-mediated cellular signaling events.

    KW - cGMP

    KW - HS

    KW - Nitric oxide

    KW - ROS

    KW - sGC activators

    UR - http://www.scopus.com/inward/record.url?scp=84979708039&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84979708039&partnerID=8YFLogxK

    U2 - 10.1016/j.phrs.2016.06.029

    DO - 10.1016/j.phrs.2016.06.029

    M3 - Article

    VL - 111

    SP - 556

    EP - 562

    JO - Pharmacological Research

    JF - Pharmacological Research

    SN - 1043-6618

    ER -